endpts.com·Jun 18, 2026
The U.S. Treasury Department is considering implementing restrictions on American investments in China's biotechnology sector, according to sources familiar with the discussions.
The most valuable insight for you is that the U.S. Treasury Department is contemplating potential restrictions on investments in Chinese biotech. This development could significantly impact cross-border collaborations and funding in the biotech sector, suggesting a need to closely monitor regulatory changes that could influence investment strategies and partnerships in this space.